Natural history of diabetic retinopathy in a retrospective cohort of type 1 diabetics;Historia natural de retinopatía diabética en un estudio a largo plazo en pacientes con diabetes tipo 1. Factores de riesgo para progresión a enfermedad proliferante

Revista Medica de Chile

Volumn 137, Issue 9, 2009, Pages 1145-1152

  Verdaguer, Juan ^a   Zanolli, Mario ^a   Sepúlveda, Gonzalo ^a   García de los Ríos, Manuel ^b   Domínguez, Angélica ^c  

^a UNIVERSIDAD DE LOS ANDES   (Chile)

^b UNIVERSITY OF CHILE   (Chile)

^c PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

Author keywords

Diabetes mellitus; Diabetic nephropathies; Diabetic retinopathy; Type 1

Indexed keywords

ADULT; AGED; ARTICLE; CHILE; DIABETIC NEPHROPATHY; DIABETIC RETINOPATHY; DISEASE COURSE; DRUSEN; EPIDEMIOLOGY; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MALE; MIDDLE AGED; PREGNANCY; RISK FACTOR; TIME;

ADULT; AGED; CHILE; DIABETES MELLITUS, TYPE 1; DIABETIC NEPHROPATHIES; DIABETIC RETINOPATHY; DISEASE PROGRESSION; EPIDEMIOLOGIC METHODS; FEMALE; HUMANS; MALE; MIDDLE AGED; PREGNANCY; RETINAL DRUSEN; RISK FACTORS; TIME FACTORS;

EID: 70450192557     PISSN: 00349887     EISSN: 07176163     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. AIELLO LP, CAHILL MT, WONG JS. Systemic considerations in the management of diabetic retinopathy. Am J Ophthalmol 2001; 132: 760-76.
2. TAYLOR HR, KEEFFE JE. World blindness: a 21st century perspective. Br J Ophthalmol 2001; 85: 261-6.
3. THE EURODIAB PROSPECTIVE COMPLICATIONS STUDY GROUP. Risk factors for progression to proliferative diabetic retinopathy in the EURODIAB Prospective Complications Study. Diabetologia 2001; 44: 2203-9.
4. KLEIN R, KLEIN BE. Diabetic eye disease. Lancet 1997; 350: 197-204.
5. KLEIN R, KLEIN BE, MOSS SE, DAVIS MD, DEMETS DL. The Wisconsin Epidemiologic Study of Diabetic Retinopathy II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol 1984; 102: 520-6.
6. GOLDSTEIN DE, BLINDER KJ, IDE CH, WILSON RJ, WIEDMEYER HM, LITTLE RR ET AL. Glycemic control and development of retinopathy in youth-onset insulin-dependent diabetes mellitus. Results of a 12-year longitudinal study. Ophthalmology 1993; 100: 1125-31.
7. THE DIABETES CONTROL AND COMPLICATIONS TRIAL RESEARCH GROUP: The effect of intensive treatment of diabetes on the development and progression of longterm complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329: 977-86.
8. OLSEN BS, JOHANNESEN J, SJOLIE AK, BORCH-JOHNSEN K, HOUGARRDSS P, THORSTEINSSON B ET AL. Metabolic control and prevalence of microvascular complications in young Danish patients with type 1 diabetes mellitus. Diabet Med 1999; 16: 79-85.
9. WILKINSON CP, FERRIS F, KLEIN R, LEE P, AGARDH CD, DAVIS M ET AL. Proposed International Clinical Diabetic Retinopathy and Diabetic Macular Edema Disease Severity Scales. Ophthalmology 2003; 110: 1677-82.
10. HOLLADAY JT. Visual Acuity Measurement. J Cataract Refract Surg 2004; 30: 287-90.
11. MAY EE, BLAYDES SH. Progressive ultrastructural damage and thickening of the basement membrane of the retinal pigment epithelium in spontaneously diabetic BB rats. Exp Eye Res 1988; 46: 545-58.
12. MACGREGOR LC, MATSCHINSKY FM. Experimental diabetes mellitus impairs the function of the retinal pigmented epithelium. Metabolism 1986; 35 (4 Suppl 1): 28-34.
13. AIZU Y, OYANAGI K, HU J, NAKAGAWA H. Degeneration of retinal neuronal processes and pigment epithelium in the early stage of the streptozotocin-diabetic rats. J Biol Chem 1986; 261: 4046-51.
14. KIRBER WM, NICHOLS CW, GRIMES PA, WINEGRAD AI, LATIES AM. A permeability defect of the retinal pigment epithelium. Occurrence in early streptozocin diabetes. Arch Ophthalmol 1980; 98: 725-8.
15. HENRICSSON M, NYSTR L, BLOHMÉ G, ÖSTAM J, KULLBERG C, SVENSSON M ET AL. The Incidence of Retinopathy 10 Years After Diagnosis in Young Adult People With Diabetes. Diabetes Care 2003; 26: 349-54.
16. LECAIRE T, PALTA M, ZHANG H, ALLEN C, KLEIN R, D'ALESSIO D. Lower-than-Expected Prevalence and Severity of Retinopathy in an Incident Cohort followed during the First 4-14 Years of Type 1 Diabetes. Am J Epidemiol 2006; 164: 143-50.
17. SKRIVARHAUG T, FOSMARK DS, STENE LC, BANGSTAD HJ, SANDVIK L, HANSSEN KF, JONER G. Low cumulative incidence of proliferative retinopathy in childhoodonset type 1 diabetes: a 24-year follow-up study. Diabetologia 2006; 49: 2281-90.
18. HOVIND P, TARNOW L, ROSSING K, ROSSING P, EISING S, LARSEN N, BINDER C, PARVING HH. Decreasing incidence of severe diabetic microangiopathy in type 1 diabetes. Diabetes Care 2003; 26: 1258-64.
19. NORDWALL M, BOJESTIG M, ARNQVIST HJ, LUDVIGSSON J, LINKÖPING DIABETES COMPLICATIONS STUDY. Declining incidence of severe retinopathy and persisting decrease of nephropathy in an unselected population of type 1 diabetes The Linkøping Diabetes Complications Study. Diabetologia 2004; 47: 1266-72.
20. KNUDSEN LL, LERVANG H-H, LUNDBYE-CHRISTENSEN S, GORST-RASMUSSEN A. The North Jutland County Diabetic Retinopathy Study: population characteristics. Br J Ophthalmol 2006; 90; 1404-9.
21. ROMERO P, SALVAT M, FERNÁNDEZ J, BAGET M, MARTÍNEZ I. Renal and retinal microangiopathy after 15 years of follow-up study in a sample of Type 1 diabetes mellitus patients. J Diabetes Complications 2007; 21: 93-100.
22. LöVESTAM-ADRIAN M, AGARDH E, AGARDH C. The incidence of nephropathy in type I diabetic patients with proliferative retinopathy, a 10 year follow-up study. Diabetes Res Clin Pract 1998; 39: 11-7.
23. KLEIN R, MOSS S, KLEIN B. Is gross proteinuria a risk factor for the incidence of proliferative diabetic retinopathy? Ophthalmology 1993; 100: 1140-6.
24. KOFOED-ENEVOLDSEN A, JENSEN T, BORCH-JOHNSEN K, DECKERT T. Incidence of retinopathy in type I (insulin-dependent) diabetes, association with clinical nephropathy. J Diab Complications 1987; 1: 96-9.
25. RAHMAN W, RAHMAN F, YASSIN S, AL-SULEIMAN S, RAHMAN J. Progression of retinopathy during pregnancy in type 1 diabetes mellitus. Clinical and Experimental Ophthalmology 2007; 35: 231-6.
26. DI LANDRO D, KOENIGSRAINER L, OEFNER D, AICHBERGER C, ROMAGNOLI GF, MARGREITER R. Experience with 100 combined pancreatic renal transplantation in a single center. Nephron 1996; 72: 547-51.
27. SCHEIDER A, MEYER-SCHWICKERATH V, NUSSER J, LAND W, LANDGRAF R. Diabetic retinopathy and pancreas transplantation: a 3-year follow-up. Diabetologia 1991; 34 (Suppl. 1): S95-99.
28. CALDARA R, BANDELLO F, VIGANO C, SECCHI A, CASTOLDI R, CALDI M ET AL. Influence of successful pancreaticorenal transplantation on diabetic retinopathy. Transpl Proc 1994; 26: 490.
29. PETERSEN MR, VINE AK. Progression of diabetic retinopathy after pancreas transplantation. Ophthalmology 1990; 97: 496-500.
30. WANG Q, KLEIN R, MOSS SE, KLEIN BE, HOYER C, BURKE K ET AL. The influence of combined kidney-pancreas transplantation on the progression of diabetic retinopathy. Ophthalmology 1994; 101: 1071-6.
31. CHOW VCC, PAI RP, CHAPMAN JR, O'CONNELL PJ, ALLEN RDM, MITCHELL P ET AL. Diabetic retinopathy after combined kidney-pancreas transplantation. Clin Transplantation 1999; 13: 356-62.